OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
July 02, 2021
Understanding the process and product goals is just the first step to a holistic approach to process development.
July 01, 2021
New biologic modalities, such as cell and gene therapies, pose increasing difficulties in viral clearance testing methods.
New challenges in extractable and leachable studies for cell and gene therapy products.
June 01, 2021
Recent innovations in chromatography resins offer promising advantage in downstream bioprocessing.
April 16, 2021
Sartorius has expanded in the United Kingdom with the relocation to a new facility in Havant, Hampshire, for downstream processing equipment.
April 02, 2021
A series of minute virus of mice spiking studies were performed with a monoclonal antibody product and small-scale AEX membrane adsorbers to evaluate a range of critical processing conditions.
January 28, 2021
The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A platform.
January 02, 2021
The development of an innovative purification process simplifies downstream processing for biologics.
December 02, 2020
Establishing an automated inline dilution system can potentially ease bottlenecking delays resulting from higher upstream yields.
Viral clearance processes and guidance must evolve along with newer biotherapeutic modalities.